| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-10 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |